✦ LIBER ✦

Treatment of hairy-cell leukemia with recombinant alpha2-interferon

✍ Scribed by Berneman, Z.N.; Gastl, G.; Gangji, D.; van Camp, B.; Jochmans, K.; Aulitzky, W.; Flament, J.; Peetermans, M.E.; Huber, C.

Book ID: 121986879
Publisher: Elsevier Science
Year: 1986
Weight: 456 KB
Volume: 22
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(86)90066-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of hairy cell leukemia with al

Treatment of hairy cell leukemia with alpha interferons

✍ Jorge R. Quesada; Jordan U. Gutterman; Evan M. Hersh 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 2 views

Hairy cell leukemia and mucormycosis. Tr

Hairy cell leukemia and mucormycosis. Treatment with alpha-2 interferon

✍ Charles L. Bennett; Carol A. Westbrook; Benjamin Gruber; Harvey M. Golomb 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Recombinant alpha-2 interferon for treat

Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy

✍ W.Christopher Ehmann; Robert Silber 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 352 KB

Human recombinant interferon-alpha in th

Human recombinant interferon-alpha in the treatment of patients with hairy cell leukemia

✍ A.B. Skotnicki; T. Wolska-Smolen; J. Blicharski; A. Zdunczyk; U. Sasiadek; A. Pi 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Interferon and inducers: Recombinant int

Interferon and inducers: Recombinant interferon alpha-C in hairy cell leukemia

✍ D. Aderka; J. Shoham; T. Doerner; M. Revel 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Recombinant beta-serine-interferon in ha

Recombinant beta-serine-interferon in hairy cell leukemia compared prospectively with results with recombinant alpha-interferon

✍ John A. Glaspy; Steven G. Marcus; Jan Ambersley; David W. Golde 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 1 views

Ten patients with hairy cell leukemia (HCL) requiring therapy were treated with recombinant beta-serineinterferon (rIFN-Bser) (90 X lo6 units [Ul subcutaneously three times a week). Eight patients were evaluable for response and nine for toxicity. Five patients (63%) showed normalization of peripher